vs

Side-by-side financial comparison of Energy Recovery, Inc. (ERII) and Vericel Corp (VCEL). Click either name above to swap in a different company.

Vericel Corp is the larger business by last-quarter revenue ($92.9M vs $66.9M, roughly 1.4× Energy Recovery, Inc.). Energy Recovery, Inc. runs the higher net margin — 40.2% vs 25.0%, a 15.2% gap on every dollar of revenue. On growth, Vericel Corp posted the faster year-over-year revenue change (23.3% vs -0.3%). Vericel Corp produced more free cash flow last quarter ($12.8M vs $6.4M). Over the past eight quarters, Vericel Corp's revenue compounded faster (34.6% CAGR vs 8.1%).

Energy Recovery Inc. is an American manufacturer of energy recovery devices for water and CO2 refrigeration industries.

Vericel Corporation is a publicly traded American biopharmaceutical company which was known prior to October 2014 as Aastrom Bio. Aastrom Bio was formed in 1989 in Ann Arbor, Michigan.

ERII vs VCEL — Head-to-Head

Bigger by revenue
VCEL
VCEL
1.4× larger
VCEL
$92.9M
$66.9M
ERII
Growing faster (revenue YoY)
VCEL
VCEL
+23.6% gap
VCEL
23.3%
-0.3%
ERII
Higher net margin
ERII
ERII
15.2% more per $
ERII
40.2%
25.0%
VCEL
More free cash flow
VCEL
VCEL
$6.4M more FCF
VCEL
$12.8M
$6.4M
ERII
Faster 2-yr revenue CAGR
VCEL
VCEL
Annualised
VCEL
34.6%
8.1%
ERII

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ERII
ERII
VCEL
VCEL
Revenue
$66.9M
$92.9M
Net Profit
$26.9M
$23.2M
Gross Margin
67.2%
78.7%
Operating Margin
46.8%
24.1%
Net Margin
40.2%
25.0%
Revenue YoY
-0.3%
23.3%
Net Profit YoY
14.7%
17.3%
EPS (diluted)
$0.49
$0.46

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ERII
ERII
VCEL
VCEL
Q4 25
$66.9M
$92.9M
Q3 25
$32.0M
$67.5M
Q2 25
$28.1M
$63.2M
Q1 25
$52.6M
Q4 24
$67.1M
$75.4M
Q3 24
$38.6M
$57.9M
Q2 24
$27.2M
$52.7M
Q1 24
$12.1M
$51.3M
Net Profit
ERII
ERII
VCEL
VCEL
Q4 25
$26.9M
$23.2M
Q3 25
$3.9M
$5.1M
Q2 25
$2.1M
$-553.0K
Q1 25
$-11.2M
Q4 24
$23.5M
$19.8M
Q3 24
$8.5M
$-901.0K
Q2 24
$-642.0K
$-4.7M
Q1 24
$-8.3M
$-3.9M
Gross Margin
ERII
ERII
VCEL
VCEL
Q4 25
67.2%
78.7%
Q3 25
64.2%
73.5%
Q2 25
64.0%
73.7%
Q1 25
69.0%
Q4 24
70.2%
77.6%
Q3 24
65.1%
71.9%
Q2 24
64.6%
69.5%
Q1 24
59.0%
68.9%
Operating Margin
ERII
ERII
VCEL
VCEL
Q4 25
46.8%
24.1%
Q3 25
11.4%
5.1%
Q2 25
5.3%
-3.2%
Q1 25
-24.3%
Q4 24
38.2%
24.5%
Q3 24
18.3%
-4.3%
Q2 24
-7.4%
-11.5%
Q1 24
-90.4%
-10.7%
Net Margin
ERII
ERII
VCEL
VCEL
Q4 25
40.2%
25.0%
Q3 25
12.1%
7.5%
Q2 25
7.3%
-0.9%
Q1 25
-21.4%
Q4 24
35.0%
26.3%
Q3 24
22.0%
-1.6%
Q2 24
-2.4%
-8.9%
Q1 24
-68.3%
-7.5%
EPS (diluted)
ERII
ERII
VCEL
VCEL
Q4 25
$0.49
$0.46
Q3 25
$0.07
$0.10
Q2 25
$0.04
$-0.01
Q1 25
$-0.23
Q4 24
$0.40
$0.40
Q3 24
$0.15
$-0.02
Q2 24
$-0.01
$-0.10
Q1 24
$-0.14
$-0.08

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ERII
ERII
VCEL
VCEL
Cash + ST InvestmentsLiquidity on hand
$75.2M
$137.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$206.2M
$354.6M
Total Assets
$231.5M
$488.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ERII
ERII
VCEL
VCEL
Q4 25
$75.2M
$137.5M
Q3 25
$70.4M
$135.4M
Q2 25
$79.5M
$116.9M
Q1 25
$112.9M
Q4 24
$78.0M
$116.2M
Q3 24
$118.6M
$101.7M
Q2 24
$101.0M
$102.5M
Q1 24
$117.4M
$110.6M
Stockholders' Equity
ERII
ERII
VCEL
VCEL
Q4 25
$206.2M
$354.6M
Q3 25
$180.8M
$321.9M
Q2 25
$185.2M
$306.8M
Q1 25
$295.5M
Q4 24
$210.0M
$292.0M
Q3 24
$233.9M
$257.5M
Q2 24
$218.5M
$243.0M
Q1 24
$216.0M
$233.9M
Total Assets
ERII
ERII
VCEL
VCEL
Q4 25
$231.5M
$488.0M
Q3 25
$209.6M
$453.3M
Q2 25
$212.3M
$435.6M
Q1 25
$424.6M
Q4 24
$242.8M
$432.7M
Q3 24
$262.7M
$390.4M
Q2 24
$249.0M
$376.8M
Q1 24
$244.3M
$356.7M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ERII
ERII
VCEL
VCEL
Operating Cash FlowLast quarter
$7.1M
$15.0M
Free Cash FlowOCF − Capex
$6.4M
$12.8M
FCF MarginFCF / Revenue
9.6%
13.8%
Capex IntensityCapex / Revenue
1.0%
2.4%
Cash ConversionOCF / Net Profit
0.26×
0.65×
TTM Free Cash FlowTrailing 4 quarters
$15.8M
$24.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ERII
ERII
VCEL
VCEL
Q4 25
$7.1M
$15.0M
Q3 25
$-3.1M
$22.1M
Q2 25
$4.1M
$8.2M
Q1 25
$6.6M
Q4 24
$9.0M
$22.2M
Q3 24
$-3.0M
$10.2M
Q2 24
$8.1M
$18.5M
Q1 24
$6.5M
$7.2M
Free Cash Flow
ERII
ERII
VCEL
VCEL
Q4 25
$6.4M
$12.8M
Q3 25
$-3.5M
$19.5M
Q2 25
$4.0M
$81.0K
Q1 25
$-7.6M
Q4 24
$8.9M
$8.5M
Q3 24
$-3.2M
$-9.2M
Q2 24
$7.9M
$1.8M
Q1 24
$5.7M
$-6.8M
FCF Margin
ERII
ERII
VCEL
VCEL
Q4 25
9.6%
13.8%
Q3 25
-10.9%
28.8%
Q2 25
14.3%
0.1%
Q1 25
-14.5%
Q4 24
13.2%
11.2%
Q3 24
-8.2%
-15.9%
Q2 24
28.9%
3.4%
Q1 24
46.9%
-13.3%
Capex Intensity
ERII
ERII
VCEL
VCEL
Q4 25
1.0%
2.4%
Q3 25
1.1%
3.9%
Q2 25
0.5%
12.9%
Q1 25
27.0%
Q4 24
0.2%
18.3%
Q3 24
0.4%
33.5%
Q2 24
0.7%
31.8%
Q1 24
6.8%
27.3%
Cash Conversion
ERII
ERII
VCEL
VCEL
Q4 25
0.26×
0.65×
Q3 25
-0.81×
4.35×
Q2 25
2.02×
Q1 25
Q4 24
0.38×
1.12×
Q3 24
-0.35×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ERII
ERII

Water Segment$38.6M58%
Other$11.0M16%
Original Equipment Manufacturer$10.6M16%
Aftermarket$6.6M10%

VCEL
VCEL

MACI Implants And Kits$84.1M90%
Other$8.8M10%

Related Comparisons